Sandostatin LAR Depot

Indicated For

Acromegaly, carcinoid syndrome, VIPomas

About This Medication

# Novartis Patient Support Patient Guide: How to Get Sandostatin LAR Depot (octreotide acetate) at Low or No Cost Sandostatin LAR Depot (octreotide acetate) is a long-acting injectable medication used to treat conditions like acromegaly, carcinoid syndrome, and certain neuroendocrine tumors by mimicking somatostatin to reduce hormone secretion.[1][2] The **Novartis Patient Support** program, including the Novartis Patient Assistance Foundation (NPAF), helps eligible patients access this medication at low or no cost through copay assistance for commercially insured patients or free medication for uninsured/underinsured patients.[1][2][3] ## Who Qualifies for Novartis Patient Support? This program offers **two main tracks** to make Sandostatin LAR Depot affordable: 1. **Copay Card for Commercially Insured Patients**: If you have private insurance, you may qualify for a copay card that reduces your out-of-pocket cost to **$25 per month**, with Novartis covering up to **$15,000 per year**. This is ideal for patients facing high copays or deductibles.[program details] 2. **Free Medication via NPAF for Uninsured/Underinsured**: If you lack adequate insurance or have government coverage like Medicare without sufficient support, you can receive Sandostatin LAR Depot at **no cost** if your household income meets guidelines (typically **400-500% of the Federal Poverty Level (FPL)**) and other criteria are met.[1][2][3][program details] **Key Eligibility Requirements for NPAF**: - Reside in the US or US territory. - Limited or no prescription coverage. - Valid prescription from a US-licensed healthcare provider. - Treated outpatient. - Provide proof of income and insurance details.[1][3] Patients with insurance tied to alternative funding programs that restrict free drug assistance may not qualify.[1][2] ## About Sandostatin LAR Depot **Sandostatin LAR Depot** is an intramuscular depot injection given once every 4 weeks. It helps control symptoms and tumor growth in: - **Acromegaly**: Reduces excess growth hormone. - **Carcinoid tumors**: Manages flushing, diarrhea. - **VIPomas**: Controls watery diarrhea. Common side effects include gastrointestinal issues, gallstones, and injection site pain. Always follow your doctor's instructions and report side effects. This guide focuses on access, not medical advice—consult your healthcare provider (HCP) for treatment details.[1][2] ## Income Eligibility Breakdown NPAF income limits are based on **household size** and typically **400-500% of FPL** for uninsured/underinsured patients. Exact thresholds vary; check www.PAP.Novartis.com for current guidelines specific to Sandostatin LAR Depot.[3] Here's a sample table based on 2026 FPL (approximate; verify current levels): | Household Size | 400% FPL (Annual Income) | 500% FPL (Annual Income) | |----------------|---------------------------|---------------------------| | 1 (Individual) | $60,240 | $75,300 | | 2 (Couple) | $81,760 | $102,200 | | 3 | $103,280 | $129,100 | | 4 | $124,800 | $156,000 | *Notes*: Add ~$21,520 per additional person at 400% FPL. Proof of income (e.g., tax return, pay stubs) required. Guidelines from www.PAP.Novartis.com.[1][3][program details] ## Insurance Requirements - **Commercially Insured**: Eligible for copay help; submit insurance details.[program details] - **Uninsured/Underinsured/Government Insurance**: Eligible for free meds via NPAF, but provide **front/back copies of all insurance cards** (primary, secondary, Rx). Medicare patients may need Extra Help denial proof.[1][2][3] NPAF excludes patients with alternative funding-restricted insurance.[1] ## Step-by-Step Application Process 1. **Check Eligibility**: Visit www.PAP.Novartis.com or call **(800) 282-7630** / NPAF at **1-800-277-2254** (Mon-Fri, 9AM-6PM ET).[2][3][4][10] 2. **Gather Documents**: Proof of income, all insurance cards (front/back), prescription. No patient-only submission—HCP involvement required.[1][3] 3. **Complete Application**: Patient and HCP fill out the NPAF form (download from www.PAP.Novartis.com). Patient signs authorization; HCP attests medical necessity and signs.[1][3][10] 4. **Submit**: Fax to **1-855-817-2711** or mail to NPAF, PO Box 2529/52029, Columbus, OH 43216 or Phoenix, AZ 85072-2029. Phone start available at (800) 282-7630.[1][3][10] 5. **Follow Up**: Incomplete apps delay/deny. Opt-in for texts.[2] For copay card, call (800) 282-7630 or use online tools.[program details] ## Timeline and Delivery - **Processing**: 24-48 hours initial review; full decision in **up to 4 weeks**.[2][program details] - **Delivery**: If approved, medication shipped **directly to patient** via **temperature-controlled shipping** to maintain stability. E-scribe for refills if needed.[1][program details] **Reauthorization Required**: Yes, periodic renewal with updated docs.[program details] ## Alternatives if Denied - **Appeal**: Submit additional info or contact NPAF.[2] - **Other Programs**: Check Partnership for Prescription Assistance, NeedyMeds, or state programs. - **Patient Access Network (PAN) Foundation** or generic options if available (no biosimilars listed).[program details] - **Financial Counseling**: Ask HCP or hospital social worker. - Reapply if circumstances change.[2][3] ## Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility, terms, and guidelines can change; Novartis reserves rights to modify/discontinue. Not medical/financial advice. Verify with Novartis at (800) 282-7630 or www.PAP.Novartis.com. Consult your HCP. Novartis not liable for application errors.[1][2][3][program details] (Word count: 1028)

Program information last verified: March 29, 2026